Avinashnarayan Venkatanarayan
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, MicroRNA in disease regulation, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma(2021)133 cited
- → IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo(2014)130 cited
- → Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors(2018)72 cited
- → Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8(2014)68 cited
- → Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers(2014)54 cited
- → ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer(2016)52 cited
- → Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress(2013)43 cited
- → Dimerization Induced by C-Terminal 14–3–3 Binding Is Sufficient for BRAF Kinase Activation(2020)42 cited
- → CRAF dimerization with ARAF regulates KRAS-driven tumor growth(2022)39 cited
- → TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway(2016)38 cited